{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:56:18Z","timestamp":1760316978555,"version":"build-2065373602"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T00:00:00Z","timestamp":1330041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cytopathology"],"published-print":{"date-parts":[[2012,4,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The article by Albrow et al in this issue describes the early cervical screening program in England as being \u201cdisorganized,\u201d but goes on to describe significant improvements over 20 years. It has become one of the leading screening programs in the developed world. Liquid\u2010based technology has been embraced, but image analysis has not. The key ingredient for the NHSCSP's success is quality assurance. The scrutiny given to medical interventions has increased recently. Would the early cervical cancer cytology screening programs have passed muster if they had required this sort of validation? Using information from the Victorian Cytology Screening Services Melbourne and other Australian screening programs to guide its formulation, Australia's evidence\u2010based program differs from the NHSCSP in several ways. The screening interval is 2 years, liquid\u2010based technology is not funded, and human papillomavirus (HPV)\u2010DNA testing for the triage of atypical lesions has not been sanctioned in Australia. Albrow et al allude to the possible introduction in the future of HPV\u2010DNA testing as a primary screening tool. Cancer (Cancer Cytopathol) 2012;. \u00a9 2012 American Cancer Society.<\/jats:p>","DOI":"10.1002\/cncy.20200","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T10:17:40Z","timestamp":1330078660000},"page":"105-107","source":"Crossref","is-referenced-by-count":3,"title":["Cancer screening of the uterine cervix papanicolaou smears versus state\u2010of\u2010the\u2010art human papillomavirus testing"],"prefix":"10.1002","volume":"120","author":[{"given":"Bryan","family":"Knight","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,24]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20203"},{"key":"e_1_2_4_3_2","first-page":"120","article-title":"The Pap test missed much cervical cancer through lab's efforts","author":"Bogdanich W","year":"1987","journal-title":"Wall Street Journal."},{"key":"e_1_2_4_4_2","first-page":"17","article-title":"Physician's carelessness with pap tests is cited in procedure's high failure rate","author":"Bogdanich W","year":"1987","journal-title":"Wall Street Journal."},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1989.03420050087046"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70264-3"},{"key":"e_1_2_4_7_2","unstructured":"Bowel Cancer Australia. A spotlight on screening\u2014the importance of early diagnosis. Available at:http:\/\/www. bowelcanceraustralia.org. Accessed September2010."},{"key":"e_1_2_4_8_2","unstructured":"The British Columbia Cancer Agency. Screening Mammography Program. Available at:http:\/\/www.smpbc.ca\/default. htm. Accessed September2010."},{"key":"e_1_2_4_9_2","unstructured":"ModlinJ JenkinsP.Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities. Canberra Australia: National Health and Medical Research Council 2005."},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1990.tb120920.x"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2002.01153.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380703"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70445-7"},{"key":"e_1_2_4_14_2","unstructured":"Victorian Cervical Cancer Registry Statistical Report2002. Available at:http:\/\/www.vccr.org\/stats.html. Accessed September 2010."},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6241"}],"container-title":["Cancer Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncy.20200","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncy.20200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:13:33Z","timestamp":1760300013000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncy.20200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,24]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4,25]]}},"alternative-id":["10.1002\/cncy.20200"],"URL":"https:\/\/doi.org\/10.1002\/cncy.20200","archive":["Portico"],"relation":{},"ISSN":["1934-662X","1934-6638"],"issn-type":[{"type":"print","value":"1934-662X"},{"type":"electronic","value":"1934-6638"}],"subject":[],"published":{"date-parts":[[2012,2,24]]}}}